S'il est approuvé, l'obicetrapib, sous licence de NewAmsterdam Pharma, sera le premier inhibiteur de la CETP à être disponible en
STOCKHOLM, Sept. 2, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have
SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- DeepQure, a company pioneering a paradigm shift in hypertension treatment, today announced
SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- DeepQure, a company pioneering a paradigm shift in hypertension treatment, today announced
The proposed special resolution seeks to confer upon the board the absolute discretion to issue securities in one or more
The proposed special resolution seeks to confer upon the board the absolute discretion to issue securities in one or more
The investment will propel the commercialisation of its ZincGel batteries and advance research and development for stationary energy storage.
Nepal Joins Global Movement Amongst Major Countries Implementing New Digital Tracking System for Foreign Visitors Starting September 2025! As part of
Grab Among Most Invasive Apps as Global Study Warns of Rising Data Privacy Risks for Travellers in Southeast Asia Grab among
Researchers used a simulator to enduce dozens of brave participants with motion sickness and study their brain activity.
